Abstract:BACKGROUND: Metastatic non-small cell lung cancer (NSCLC) has many comorbidities, such as chronic obstructive pulmonary disease, coronary heart disease, and older age-related comorbidities. A survival benefit was observed in such patients who underwent surgery for selected oligometastatic disease. However, to the best of our knowledge, there is no evidence to support whether lobectomy (compared with sub-lobar resection) would further prolong these patients' lives.METHODS: Patients with metastatic NSCLC who underwent primary tumor resection were identified from the Surveillance, Epidemiology, and End Results (SEER) database and then divided into lobectomy and sub-lobar resection groups. Propensity score matching (PSM, 1:1) was performed to match the baseline characteristics of the two groups. Cancer-specific survival (CSS) was estimated.RESULTS: In total, 24,268 patients with metastatic NSCLC were identified; 4,114 (16.95%) underwent primary tumor surgery, and of these, 2,045 (49.71%) underwent lobectomy and 1,766 (42.93%) underwent sub-lobar resection. After PSM, 644 patients in each group were included. Lobectomy was independently correlated with longer median CSS time [hazards ratio (HR): 0.70, 95% confidence interval (CI): 0.61-0.80, P<0.001]. The 1, 2, and 3-year survival rates after PSM also favored the lobectomy group. However, no significant survival difference was found for wedge resection and segmentectomy (HR: 0.96, 95% CI: 0.70-1.31, P=0.490). The 1-, 2-, and 3-year survival rates after PSM also exhibited no difference within the sub-lobar group. We explored whether lymph node dissection would provide additional survival benefits for stage IV NSCLC patients. According to the multivariate Cox analysis of the matched population, lymph node dissection was independently associated with better CSS (HR: 0.76, 95% CI: 0.66-0.88, P<0.001) and overall survival (OS) (HR: 0.74, 95% CI: 0.65-0.86, P<0.001). We confirmed this result in the different types of surgery and found that the lymph node dissection group consistently had better survival outcomes both in the lobectomy group and sub-lobar resection population. According to the subgroup analysis, with the exception of stage T4 and brain metastatic patients, all of the patient subtypes exhibited greater benefit from lobectomy than sub-lobar resection.CONCLUSIONS: Lobectomy has a greater survival benefit in metastatic NSCLC patients compared with sub-lobar resection when radical treatment of primary site was indicated.

Safety and optimal pattern of second surgery for lung cancer patients with history of lung resection

Effectiveness and Safety of Systematic and Selective Lymphadenectomies in Chinese Patients with Non-Small Cell Lung Cancer Who Received Sublobar Resection.

Sublobar Resection Is Associated With Better Perioperative Outcomes In Elderly Patients With Clinical Stage I Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

Comparison of Perioperative and Survival Outcomes Between Sublobar Resection and Lobectomy of Patients Who Underwent a Second Pulmonary Resection.

Sublobar Resection for Pulmonary Aspergilloma: A Safe Alternative to Lobectomy

Survival Rates after Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.

Risk Factors of Morbidity after Pulmonary Resection for Lung Cancer in Patients Older Than 70 Years

Unplanned Perioperative Reoperation Following Pulmonary Resection in Lung Cancer Patients: A Report of a Single‐Center Experience

Efficacy of Repeated Surgery is Superior to That of Non-Surgery for Recurrent/second Primary Lung Cancer after Initial Operation for Primary Lung Cancer.

Sublobectomy Versus Lobectomy for Long-Term Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer with a Tumor Size ≤2 Cm Accompanied by Visceral Pleural Invasion: a SEER Population-Based Study

Optimizing Lung Cancer Surgery in the Elderly: Sublobar Resection Versus Lobectomy for Early-Stage Non-Small Cell Lung Cancer Patients Aged 80 and Above.

Impact of compromised pulmonary function on major lung resection for non-small cell lung cancer: retrospective study of 127 cases.

Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?

Surgery for Pre- and Minimally Invasive Lung Adenocarcinoma.

Risk of Death From Other Diseases in Lung Cancer Patients After Sublobar Resection Versus Lobectomy

Comparative Analysis of the Long-Term Outcomes of Segmentectomy and Lobectomy for Stage IA1 Lung Adenocarcinoma in Patients with or Without Previous Malignancy of Other Organs: a Population-Based Study

The Evaluation of Pneumonectomy and Bronchoplasty Lobectomy in the Treatment of Non-small Cell Lung Cancer: A Report of 64 Cases

Risk Factors of Postoperative Pulmonary Complications after Minimally Invasive Anatomic Resection for Lung Cancer.

Analysis of the pattern of recurrence after curative thoracoscopic lobectomy of non-small cell lung cancer

Effectiveness And Safety Of Lobectomy And Sublobar Dissection In Chinese Elderly Patients With Non-Small Cell Lung Cancer: A Real-World Observational Study.

Comparison of Outcomes Between Sublobar Resection and Lobectomy for T1 Non-Small Cell Lung Cancer